Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 04/30/2020

Month EndAs of 04/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 18.52 5.85 1.70 14.66 10.94
Fund with Sales Charge (%) (POP) 12.00 3.87 0.56 14.01 10.66
NASDAQ Biotechnology Index (%) 16.66 7.78 2.20 15.40 11.66
S&P 500 Index (%) 0.86 9.04 9.12 11.69 7.23
Quarter EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -1.10 1.58 -2.02 13.30 10.34
Fund with Sales Charge (%) (POP) -6.54 -0.32 -3.12 12.66 10.07
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69

After-Tax Average Annual Total Returns [further-information] As of 04/30/2020

Month EndAs of 04/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 16.10 4.51 0.21 13.20
Fund without Sales Charge (%) (NAV) After Shares Sold 12.70 4.32 1.00 11.96
Fund with Sales Charge (%) (POP) Before Shares Sold 9.71 2.55 -0.91 12.57
Fund with Sales Charge (%) (POP) After Shares Sold 8.75 2.78 0.13 11.38
Quarter EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -3.11 0.28 -3.46 11.87
Fund without Sales Charge (%) (NAV) After Shares Sold 1.17 1.18 -1.67 10.85
Fund with Sales Charge (%) (POP) Before Shares Sold -8.45 -1.59 -4.54 11.24
Fund with Sales Charge (%) (POP) After Shares Sold -2.15 -0.27 -2.49 10.28

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund without Sales Charge (%) (NAV) 34.84 -15.72 18.80 -17.16 5.50 33.91 68.64 29.35 8.35 17.28
Fund with Sales Charge (%) (POP) 27.43 -20.35 11.97 -21.92 -0.57 26.22 58.95 21.90 2.12 10.54
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97 32.29 12.08 15.25
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39 16.00 2.11 15.06

Cumulative Total Returns [further-information] As of 04/30/2020

Month EndAs of 04/30/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 4.49 -0.28 18.52 18.58 8.81 292.65 946.94
Fund with Sales Charge (%) (POP) -1.25 -5.76 12.00 12.06 2.82 271.04 889.17
NASDAQ Biotechnology Index (%) 9.11 3.00 16.66 25.22 11.48 318.99 1,112.44
S&P 500 Index (%) -9.26 -9.29 0.86 29.66 54.74 202.21 385.18
Quarter EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.44 -12.44 -1.10 4.80 -9.68 248.68 819.27
Fund with Sales Charge (%) (POP) -17.25 -17.25 -6.54 -0.96 -14.65 229.48 768.55
NASDAQ Biotechnology Index (%) -10.41 -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -19.60 -6.98 16.11 38.47 172.10 330.05

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 05/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 24.16 25.65 23.19
Standard Deviation (NASDAQ Biotechnology Index) 22.57 24.08 21.40
Beta 1.03 1.04 1.05
Sharpe Ratio 0.42 0.02 0.71
Information Ratio -0.06 -0.07 -0.10
Tracking Error 6.23 5.91 6.13

ADDITIONAL RISK STATISTICSAs of 05/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 0.96 0.94 1.03
Beta Bear 0.92 1.00 1.02
Bull Bear Capture Ratio 1.01 1.04 0.99
Gains/Losses 1.52 1.15 1.79

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 1.04%
Net Expense Ratio [further-information] 1.02%
Max Initial Sales Charge 5.50%
CDSC 1.00%

Volatility Measures [further-information] As of 05/31/2020 Updated Monthly, based on a 3-year period

Beta 1.03
Sharpe Ratio 0.42
Standard Deviation 24.16

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index